Skip to content


Designing nanopar­ti­cles that can get genetic medicines to their targets

Gene-based medicines, in the form of DNA, RNA, and ribonuclear proteins, promise to help treat many diseases caused by genetic mutations. But one huge challenge of genetic medicine has been figuring out how to deliver these fragile molecules to the right places in the body. Genedit designs polymer nanopar­ti­cles of varied size, charge, and composition that can selectively deliver genetic payloads to specific tissues such as in the lungs or the central nervous system.

Explore Companies